The patent results from a divisional application of EP 09732113/2 291 195, and relates to a vaccine for protection against Lawsonia intracellularis, Mycoplasma hyopneumoniae and Porcine circo virus.
Brief outline of the case
The OD held inter alia that the sole claim of the patent as granted (claim 1) did not contain subject-matter which extended beyond the content of the application and the earlier application,